RT Journal Article SR Electronic T1 Spinocerebellar ataxia type 4 is caused by a GGC expansion in the ZFHX3 gene and is associated with prominent dysautonomia and motor neuron signs JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2023.10.03.23296230 DO 10.1101/2023.10.03.23296230 A1 Paucar, Martin A1 Nilsson, Daniel A1 Engvall, Martin A1 Laffita-Mesa, José A1 Söderhäll, Cilla A1 Skorpil, Mikael A1 Halldin, Christer A1 Fazio, Patrik A1 Lagerstedt-Robinson, Kristina A1 Solders, Göran A1 Angeria, Maria A1 Varrone, Andrea A1 Risling, Mårten A1 Jiao, Hong A1 Nennesmo, Inger A1 Wedell, Anna A1 Svenningsson, Per YR 2023 UL http://medrxiv.org/content/early/2023/10/03/2023.10.03.23296230.abstract AB Background Spinocerebellar ataxias (SCAs) are a group of heterogeneous autosomal dominant disorders. Spinocerebellar ataxia 4 (SCA4), one of the rarest SCAs, is characterized by adult-onset ataxia, polyneuropathy and linked to chromosome 16q22.1, the underlying mutation remains to be discovered.Methods Three Swedish families affected by undiagnosed SCA went through detailed examinations, neurophysiological tests, neuroimaging studies and genetic testing. Imaging included MRI of the neuroaxis and brain PET. In 3 cases neuropathological assessments were performed. Genetic testing included SR WGS, STR analysis with Expansion Hunter de novo and long read (LR) WGS.Results Novel features such as dysautonomia, motor neuron affection, and abnormal eye movements, were found. Anticipation was documented as well. Atrophy in the cerebellum, brainstem and spinal cord was found in patients studied with MRI. [18F]FDG-PET demonstrated brain hypometabolism whereas [11C]Flumazenil-PET yielded reduced binding in several brain lobes, insula, thalamus, hypothalamus and cerebellum. Neuropathological assessment revealed moderate to severe loss of Purkinje cells in the cerebellum. In the spinal cord a marked loss of motor neurons in the anterior horns was seen as well as pronounced degeneration of posterior tracts. Intranuclear, mainly neuronal, inclusions positive for p62 and ubiquitin were sparse but widespread in the CNS. This finding prompted assessment for nucleotide expansions. A poly-glycine stretch encoding GGC expansions in the last exon of the zink finger homeobox 3 (ZFHX3) gene was identified segregating with disease, and not found in 1000 controls.Conclusions SCA4 is a neurodegenerative disease, caused by a novel GGC expansion in ZFHX3, arguably the first polyglycine disorder in humans.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRegion StockholmAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Swedish Ethical Review AuthorityI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscriptSCA4Spinocerebellar ataxia type 4